There is a great need in the Chinese market for quality Vitamin K2 products that meet the new GB standard for Vitamin K2 in China. NattoPharma, the Vitamin K2 leader, is helping Chinese manufacturers address this need as easily as possible.
To that end, the company has introduced its new MenaQ7® Natto MK-7, a clinically validated and patented soy-based Vitamin K2 ingredient fermented with Bacillus natto that is in line with the new GB Standard for Vitamin K2 in China.
NattoPharma and its partner Prochin will be showcasing MenaQ7® Natto MK-7 at Hi/Fi in Shanghai, China 20-22 June 2017 at Stand E5D21.
Here is your opportunity to learn more before the show opens.